ESTA(Establishment Labs Holdings Inc.) · 财务报表

ESTA(Establishment Labs Holdings Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$126.68M$161.70M$165.15M$166.03M$211.08M
毛利润$85.40M$106.59M$106.98M$109.53M$146.31M
营业利润−$25.14M−$39.66M−$65.03M−$49.99M−$39.01M
净利润−$41.14M−$75.21M−$78.50M−$84.60M−$51.06M
经营现金流−$27.53M−$52.17M−$88.51M−$58.52M−$50.89M
自由现金流−$29.96M−$55.02M−$96.42M−$64.63M−$56.94M
摊薄每股收益$-1.72$-3.08$-3.07$-3.00$-1.72

Establishment Labs Holdings Inc. ESTA